THIS report describes the clinical, laboratory and genetic investigations of a large Negro family, many of whose members exhibit choreiform movements of early onset and nonprogressive nature. As far ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 3 KINECT®-DCP study evaluating the efficacy, safety, and tolerability of valbenazine in pediatric and adult participants who ...

Background A 75-year-old woman with rheumatoid arthritis presented with a 4-year history of chorea to a hospital movement disorder clinic. The involuntary movements were initially mild, affecting only ...

Chorea gravidarum is uncommon movement disorder of pregnancy, characterized by involuntary, abrupt, non-rhythmic movements. It can be idiopathic or secondary to the underlying pathology. A 28-year-old ...

The KINECT-DCP trial evaluated the efficacy and safety of valbenazine in patients with dyskinesia due to cerebral palsy who experience choreiform movements.

Chorea gravidarum is a rare movement disorder that occurs during pregnancy. It causes involuntary, rapid, and irregular movements affecting the face, limbs, and trunk. This rare condition can have ...

Chorea is a movement disorder that causes involuntary, unpredictable body movements. Symptoms may include fidgeting to severe uncontrolled arm and leg movements. Chorea is a movement disorder that ...

DEERFIELD, Ill.--(BUSINESS WIRE)--OVATION Pharmaceuticals, Inc. announced today that Xenazine * (tetrabenazine) Tablets, an orphan drug recently approved by the U.S. Food and Drug Administration (FDA) ...

Neurocrine Biosciences has reported that its Phase III trial assessing the selective vesicular monoamine transporter 2 (VMAT2) inhibitor, valbenazine, for dyskinetic cerebral palsy in paediatric and ...

This page lists all known medications that could potentially lead to 'Chorea' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...